Johnson BG - Search Results

1

Sigma opioid receptor: characterization and co-identity with the phencyclidine receptor.

Mendelsohn LG, Kalra V, Johnson BG, Kerchner GA. Mendelsohn LG, et al. Among authors: johnson bg. J Pharmacol Exp Ther. 1985 Jun;233(3):597-602. J Pharmacol Exp Ther. 1985. PMID: 2989489

2

Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.

Mendelsohn LG, Johnson BG, Scott WL, Frederickson RC. Mendelsohn LG, et al. Among authors: johnson bg. J Pharmacol Exp Ther. 1985 Aug;234(2):386-90. J Pharmacol Exp Ther. 1985. PMID: 3894620

3

Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptors.

Zimmerman DM, Leander JD, Cantrell BE, Reel JK, Snoddy J, Mendelsohn LG, Johnson BG, Mitch CH. Zimmerman DM, et al. Among authors: johnson bg. J Med Chem. 1993 Oct 1;36(20):2833-41. doi: 10.1021/jm00072a001. J Med Chem. 1993. PMID: 8410998

4

3,4-Dimethyl-4-(3-hydroxyphenyl)piperidines: opioid antagonists with potent anorectant activity.

Mitch CH, Leander JD, Mendelsohn LG, Shaw WN, Wong DT, Cantrell BE, Johnson BG, Reel JK, Snoddy JD, Takemori AE, et al. Mitch CH, et al. Among authors: johnson bg. J Med Chem. 1993 Oct 1;36(20):2842-50. doi: 10.1021/jm00072a002. J Med Chem. 1993. PMID: 8410999

5

Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo.

Weiss B, Alt A, Ogden AM, Gates M, Dieckman DK, Clemens-Smith A, Ho KH, Jarvie K, Rizkalla G, Wright RA, Calligaro DO, Schoepp D, Mattiuz EL, Stratford RE, Johnson B, Salhoff C, Katofiasc M, Phebus LA, Schenck K, Cohen M, Filla SA, Ornstein PL, Johnson KW, Bleakman D. Weiss B, et al. J Pharmacol Exp Ther. 2006 Aug;318(2):772-81. doi: 10.1124/jpet.106.101428. Epub 2006 May 11. J Pharmacol Exp Ther. 2006. PMID: 16690725

6

Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).

Rorick-Kehn LM, Johnson BG, Burkey JL, Wright RA, Calligaro DO, Marek GJ, Nisenbaum ES, Catlow JT, Kingston AE, Giera DD, Herin MF, Monn JA, McKinzie DL, Schoepp DD. Rorick-Kehn LM, et al. Among authors: johnson bg. J Pharmacol Exp Ther. 2007 Apr;321(1):308-17. doi: 10.1124/jpet.106.110809. Epub 2007 Jan 4. J Pharmacol Exp Ther. 2007. PMID: 17204749

7

Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysis.

Watts SW, Cox DA, Johnson BG, Schoepp DD, Cohen ML. Watts SW, et al. Among authors: johnson bg. J Pharmacol Exp Ther. 1994 Nov;271(2):832-44. J Pharmacol Exp Ther. 1994. PMID: 7965803

8

Improved bioavailability of the mGlu2/3 receptor agonist LY354740 using a prodrug strategy: in vivo pharmacology of LY544344.

Rorick-Kehn LM, Perkins EJ, Knitowski KM, Hart JC, Johnson BG, Schoepp DD, McKinzie DL. Rorick-Kehn LM, et al. Among authors: johnson bg. J Pharmacol Exp Ther. 2006 Feb;316(2):905-13. doi: 10.1124/jpet.105.091926. Epub 2005 Oct 13. J Pharmacol Exp Ther. 2006. PMID: 16223873

9

Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).

Fell MJ, Svensson KA, Johnson BG, Schoepp DD. Fell MJ, et al. Among authors: johnson bg. J Pharmacol Exp Ther. 2008 Jul;326(1):209-17. doi: 10.1124/jpet.108.136861. Epub 2008 Apr 18. J Pharmacol Exp Ther. 2008. PMID: 18424625 Free article.

10

In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).

Fell MJ, Perry KW, Falcone JF, Johnson BG, Barth VN, Rash KS, Lucaites VL, Threlkeld PG, Monn JA, McKinzie DL, Marek GJ, Svensson KA, Nelson DL. Fell MJ, et al. Among authors: johnson bg. J Pharmacol Exp Ther. 2009 Dec;331(3):1126-36. doi: 10.1124/jpet.109.160598. Epub 2009 Sep 15. J Pharmacol Exp Ther. 2009. PMID: 19755662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page